| Target ID: | dt701 |
|---|---|
| CID: | 3047794 |
| Compound Name: | Nolpitantium Besilate |
| Gene ID: | 5594 |
| Gene Name: | MAPK1 |
| Species: | Rattus norvegicus (Norway rat) |
| PubMed IDs: | 16788306 |
| Action: | SR140333B inhibits the reaction [capsaicin results in increased phosphorylation of MAPK1 protein] |
Knowledge Graph
| Target ID | CID | Compound Name | Gene ID | Gene Name | Species | Action | |
|---|---|---|---|---|---|---|---|
| dt1147 | 54675783 | Minocycline | 5594 | MAPK1 | Homo sapiens (human) | Inhibitor | Details |
| dt344 | 5042 | Rebamipide | 5594 | MAPK1 | Homo sapiens (human) | -- | Details |
| dt635 | 448281 | Mln-4760 | 5594 | MAPK1 | Rattus norvegicus (Norway rat) | 2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)ethylamino)-4-methylpentanoic acid inhibits the reaction [lipopolysaccharides results in increased phosphorylation of MAPK1 protein] | Details |
| dt684 | 969516 | Curcumin | 5594 | MAPK1 | Rattus norvegicus (Norway rat) | Curcumin inhibits the reaction [tetracaine results in increased phosphorylation of MAPK1 protein] | Details |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress | |
|---|---|---|---|---|---|---|---|
| Drug83 | Nolpitantium besylate | Chemical drug | -- | -- | -- | Under clinical trials | Details |
| Compound ID | Source ID | Source Type | Compound Name | Molecular Weight | Molecular Formula | Molecular Species | |
|---|---|---|---|---|---|---|---|
| No data available | |||||||
| Disease ID | Disease Name | Definition | Mechanism | |
|---|---|---|---|---|
| No data available | ||||
| Strategy ID | Therapy Strategy | Synonyms | Related Drugs | Mechanism | |
|---|---|---|---|---|---|
| No data available | |||||